Cargando…
A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota: a Pilot Study
To address the emergence of antimicrobial-resistant pathogens in livestock, microbiome-based strategies are increasingly being sought to reduce antimicrobial use. Here, we describe the effects of intranasal application of bacterial therapeutics (BTs) on the bovine respiratory microbiota and used str...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134831/ https://www.ncbi.nlm.nih.gov/pubmed/36971568 http://dx.doi.org/10.1128/msystems.01016-22 |
_version_ | 1785031838698307584 |
---|---|
author | Amat, Samat Timsit, Edouard Workentine, Matthew Schwinghamer, Timothy van der Meer, Frank Guo, Yongmei Alexander, Trevor W. |
author_facet | Amat, Samat Timsit, Edouard Workentine, Matthew Schwinghamer, Timothy van der Meer, Frank Guo, Yongmei Alexander, Trevor W. |
author_sort | Amat, Samat |
collection | PubMed |
description | To address the emergence of antimicrobial-resistant pathogens in livestock, microbiome-based strategies are increasingly being sought to reduce antimicrobial use. Here, we describe the effects of intranasal application of bacterial therapeutics (BTs) on the bovine respiratory microbiota and used structural equation modeling to investigate the causal networks after BT application. Beef cattle received (i) an intranasal cocktail of previously characterized BT strains, (ii) an injection of metaphylactic antimicrobial (tulathromycin), or (iii) intranasal saline. Despite being transient colonizers, inoculated BT strains induced longitudinal modulation of the nasopharyngeal bacterial microbiota while showing no adverse effect on animal health. The BT-mediated changes in bacteria included reduced diversity and richness and strengthened cooperative and competitive interactions. In contrast, tulathromycin increased bacterial diversity and antibiotic resistance and disrupted bacterial interactions. Overall, a single intranasal dose of BTs can modulate the bovine respiratory microbiota, highlighting that microbiome-based strategies have potential in being utilized to mitigate bovine respiratory disease in feedlot cattle. IMPORTANCE Bovine respiratory disease (BRD) remains the most significant health challenge affecting the North American beef cattle industry and results in $3 billion in economic losses yearly. Current BRD control strategies mainly rely on antibiotics, with metaphylaxis commonly employed to mitigate BRD incidence in commercial feedlots. However, the emergence of multidrug-resistant BRD pathogens threatens to reduce the efficacy of antimicrobials. Here, we investigated the potential use of novel bacterial therapeutics (BTs) to modulate the nasopharyngeal microbiota in beef calves, which are commonly administered metaphylactic antibiotics to mitigate BRD when sourced from auction markets. By direct comparison of the BTs with an antibiotic commonly used for BRD metaphylaxis in feedlots, this study conveyed the potential use of the BTs to modulate respiratory microbiome and thereby improve resistance against BRD in feedlot cattle. |
format | Online Article Text |
id | pubmed-10134831 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-101348312023-04-28 A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota: a Pilot Study Amat, Samat Timsit, Edouard Workentine, Matthew Schwinghamer, Timothy van der Meer, Frank Guo, Yongmei Alexander, Trevor W. mSystems Research Article To address the emergence of antimicrobial-resistant pathogens in livestock, microbiome-based strategies are increasingly being sought to reduce antimicrobial use. Here, we describe the effects of intranasal application of bacterial therapeutics (BTs) on the bovine respiratory microbiota and used structural equation modeling to investigate the causal networks after BT application. Beef cattle received (i) an intranasal cocktail of previously characterized BT strains, (ii) an injection of metaphylactic antimicrobial (tulathromycin), or (iii) intranasal saline. Despite being transient colonizers, inoculated BT strains induced longitudinal modulation of the nasopharyngeal bacterial microbiota while showing no adverse effect on animal health. The BT-mediated changes in bacteria included reduced diversity and richness and strengthened cooperative and competitive interactions. In contrast, tulathromycin increased bacterial diversity and antibiotic resistance and disrupted bacterial interactions. Overall, a single intranasal dose of BTs can modulate the bovine respiratory microbiota, highlighting that microbiome-based strategies have potential in being utilized to mitigate bovine respiratory disease in feedlot cattle. IMPORTANCE Bovine respiratory disease (BRD) remains the most significant health challenge affecting the North American beef cattle industry and results in $3 billion in economic losses yearly. Current BRD control strategies mainly rely on antibiotics, with metaphylaxis commonly employed to mitigate BRD incidence in commercial feedlots. However, the emergence of multidrug-resistant BRD pathogens threatens to reduce the efficacy of antimicrobials. Here, we investigated the potential use of novel bacterial therapeutics (BTs) to modulate the nasopharyngeal microbiota in beef calves, which are commonly administered metaphylactic antibiotics to mitigate BRD when sourced from auction markets. By direct comparison of the BTs with an antibiotic commonly used for BRD metaphylaxis in feedlots, this study conveyed the potential use of the BTs to modulate respiratory microbiome and thereby improve resistance against BRD in feedlot cattle. American Society for Microbiology 2023-03-27 /pmc/articles/PMC10134831/ /pubmed/36971568 http://dx.doi.org/10.1128/msystems.01016-22 Text en © Crown copyright 2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Amat, Samat Timsit, Edouard Workentine, Matthew Schwinghamer, Timothy van der Meer, Frank Guo, Yongmei Alexander, Trevor W. A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota: a Pilot Study |
title | A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota: a Pilot Study |
title_full | A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota: a Pilot Study |
title_fullStr | A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota: a Pilot Study |
title_full_unstemmed | A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota: a Pilot Study |
title_short | A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota: a Pilot Study |
title_sort | single intranasal dose of bacterial therapeutics to calves confers longitudinal modulation of the nasopharyngeal microbiota: a pilot study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134831/ https://www.ncbi.nlm.nih.gov/pubmed/36971568 http://dx.doi.org/10.1128/msystems.01016-22 |
work_keys_str_mv | AT amatsamat asingleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy AT timsitedouard asingleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy AT workentinematthew asingleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy AT schwinghamertimothy asingleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy AT vandermeerfrank asingleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy AT guoyongmei asingleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy AT alexandertrevorw asingleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy AT amatsamat singleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy AT timsitedouard singleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy AT workentinematthew singleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy AT schwinghamertimothy singleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy AT vandermeerfrank singleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy AT guoyongmei singleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy AT alexandertrevorw singleintranasaldoseofbacterialtherapeuticstocalvesconferslongitudinalmodulationofthenasopharyngealmicrobiotaapilotstudy |